Product Information
ZOLMITRIPTAN 2.5 MG ODT is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $2.0682 per EA under NDC 62332018106. Its NADAC has been published 120 times since Jun 19, 2024.
FDA first approved this application on Dec 1, 2016. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
2.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332018106
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ZOLMITRIPTANApproval Type
Generic (ANDA)
FDA Application
ANDA205074FDA Approved
12/1/2016
TE Code
AB
On Market Since
1/10/2024
Pharmacological Classes
Price Statistics
The NADAC for ZOLMITRIPTAN 2.5 MG ODT has been published 120 times since Jun 19, 2024, and over the history we have for it it has declined 30.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.0682 per EA |
|---|---|
| All-time high | $2.9910 (May 14, 2025) |
| All-time low | $2.0682 (Sep 23, 2026) |
| 52-week high | $2.4682 |
| 52-week low | $2.0682 |
| Median price | $2.3628 |
| Average price | $2.3892 |
| Largest weekly change | -27.1% (Jul 17, 2024) |
| Weeks tracked | 120 |
| Tracking since | Jun 19, 2024 |
Generic Alternatives
The matcher finds 10 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alembic Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Zolmitriptan market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin-1b and Serotonin-1d Receptor Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ZOLMITRIPTAN 2.5 MG ODT?
The current National Average Drug Acquisition Cost (NADAC) for ZOLMITRIPTAN 2.5 MG ODT, manufactured by Alembic Pharmaceuticals Inc., is $2.0682 per EA (NDC 62332018106), effective Sep 30, 2026.
How has the price of ZOLMITRIPTAN 2.5 MG ODT changed over time?
Over the history we have for it, the NADAC for ZOLMITRIPTAN 2.5 MG ODT has declined 30.2%. It has been tracked across 120 weekly CMS publications since Jun 19, 2024.
What are the highest and lowest recorded NADAC prices for ZOLMITRIPTAN 2.5 MG ODT?
Since Jun 19, 2024, the NADAC for ZOLMITRIPTAN 2.5 MG ODT has ranged from a low of $2.0682 (Sep 23, 2026) to a high of $2.9910 (May 14, 2025), with a median of $2.3628 per EA.
Are there cheaper alternatives to ZOLMITRIPTAN 2.5 MG ODT?
Yes. 10 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ZOLMITRIPTAN 2.5 MG TABLET, is $1.0228 per EA — about 51% below ZOLMITRIPTAN 2.5 MG ODT.
Who manufactures ZOLMITRIPTAN 2.5 MG ODT?
ZOLMITRIPTAN 2.5 MG ODT (NDC 62332018106) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.